Novartis AG

M&A in pharma sees deals worth $14.8 bn in Nov 2024

Read more

Biocon expands its generic formulations, launches Everolimus tablets in US

Read more

Novartis pays $729 million to settle US kickback charges

Read more

Novartis to test efficacy of old malaria drug against COVID-19

Read more

Eris Lifesciences acquires trademark Zomelis (for Vildagliptin) from Novartis AG for India market

Read more